MECOM and familial pancreatic carcinoma: Our studies cannot distinguish which forms of PRDM3 are necessary for its anti-tumor effect in acinar cells, therefore, more work will be needed to examine the effects of different PRDM3 isoforms on pancreatitis and pancreatic cancer initiation.